55 results
8-K
EX-1.1
MTNB
Matinas Biopharma Holdings Inc
5 Apr 24
Matinas BioPharma Announces Registered Direct Offering of $10 Million
7:00am
of the total amount of Placement Agent Securities sold. The Placement Agent reserves the right to reduce any item of compensation, including the reimbursement … received as reimbursement of expenses incurred by the Placement Agent).
These indemnification provisions shall remain in full force and effect
8-K
EX-10.1
MTNB
Matinas Biopharma Holdings Inc
5 Apr 24
Matinas BioPharma Announces Registered Direct Offering of $10 Million
7:00am
of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf
424B5
MTNB
Matinas Biopharma Holdings Inc
7 Jul 23
Prospectus supplement for primary offering
5:25pm
therapies and products that are or may become available;
uncertainties of government and third party payor reimbursement;
the performance of third parties
424B5
33e 2a4fw
10 Aug 20
Prospectus supplement for primary offering
4:05pm